{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:29Z","timestamp":1791224909618,"version":"4.1.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>Parkinson's disease represents a major healthcare burden with over 1 million confirmed cases and economic costs of care exceeding $50 billion in the United States alone. A challenge in the evaluation of potentially disease delaying, preventing, or reversing agents is identification of patients in the very early, prodromal (asymptomatic, non-motor, or early motor) stages, which can span decades. Currently, diagnosis is based almost exclusively on clinical history and physical examination conducted by trained experts. Unfortunately for many patients, access to neurology and movement disorder specialists is geographically limited and coupled with the absence of coordinated disease awareness campaigns can contribute to substantial delays in diagnosis. As with any campaign, a key success factor is having multiple approaches which can appeal to a wide range of patient archetypes. Herein we elaborate on some emerging opportunities, which if fully developed could invigorate the approach to early detection and, critically, engage patients in this process. They include 1) Use of personal digital health technologies and community based point-of-care diagnostic instrumentation, 2) The potential to leverage annual testing services at non-traditional venues including optometry, dental and pharmacy, and 3) A consumer focused campaign to raise awareness of the importance of early detection, paralleling efforts in other diseases. There is every hope that combining traditional and non-traditional approaches to enhance early diagnosis rates can have an overall positive impact on patient outcomes and contribute substantively to efforts to develop new interventions. We urge the community to embrace these possibilities and begin active dialog on how to thoughtfully implement the approaches into routine care.<\/jats:p>","DOI":"10.1177\/1877718x251336118","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:40:31Z","timestamp":1744861231000},"page":"646-653","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["The potential of distributed diagnostics for the early detection of Parkinson's disease"],"prefix":"10.1177","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9143-0218","authenticated-orcid":false,"given":"Amit","family":"Khanna","sequence":"first","affiliation":[{"name":"Neuroscience Development, Novartis AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-9893","authenticated-orcid":false,"given":"James","family":"Beck","sequence":"additional","affiliation":[{"name":"Parkinson's Foundation, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-7143","authenticated-orcid":false,"given":"Kathleen","family":"Poston","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-8280","authenticated-orcid":false,"given":"Michael A","family":"Schwarzschild","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2195-3567","authenticated-orcid":false,"given":"Graham B","family":"Jones","sequence":"additional","affiliation":[{"name":"Data, Design and Clinical Innovation, Novartis Pharmaceuticals, Cambridge, MA, USA"},{"name":"Clinical and Translational Science Institute, Tufts University Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00410-y"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0117-1"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30036-3"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51753"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00185-8"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00242-2"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-017-0039-8"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae142"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.10207"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203395"},{"key":"e_1_3_4_12_2","unstructured":"Parkinson's Progression Markers Initiative. Path to Prevention Platform Trial. https:\/\/www.ppmi-info.org\/study-design\/path-to-prevention-platform-trial"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00523-y"},{"key":"e_1_3_4_14_2","first-page":"534","article-title":"Naming the illness: the power of words","volume":"23","author":"Wood ML","year":"1991","unstructured":"Wood ML. Naming the illness: the power of words. Fam Med 1991; 23: 534\u2013538.","journal-title":"Fam Med"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00805-z"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212935"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141694"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00215"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062334"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2022.3187309"},{"key":"e_1_3_4_21_2","unstructured":"Parkinson\u2019s Foundation (Australia). Parkinson\u2019s disease: Early detection and monitoring with KeySense. https:\/\/www.parkinsons-research.org\/index.htm? gad=1&gclid=CjwKCAjwjaWoBhAmEiwAXz8DBaYxR67hIzjWm303_Jq1tVMWMclXtAHCMV_SHfml8G27QJvRoAx0gBoC5UQQAvD_BwE (accessed 21 September 2023)"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2018.0271"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02681-y"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1204733"},{"key":"e_1_3_4_25_2","unstructured":"Parkinson\u2019s Progressive Markers Initiative. Data User Guide. https:\/\/www.ppmi-info.org\/sites\/default\/files\/docs\/PPMI%20Data%20User%20Guide.pdf"},{"key":"e_1_3_4_26_2","first-page":"1672","article-title":"Expanding the PD GENEration study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson\u2019s disease (PD) populations [abstract]","volume":"39","author":"Ghosh Galvelis K","year":"2024","unstructured":"Ghosh Galvelis K, Naito A, Dini M, et al. Expanding the PD GENEration study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson\u2019s disease (PD) populations [abstract]. Mov Disord 2024; 39: 1672.","journal-title":"Mov Disord"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00162-1"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51236"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01932-x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adc9669"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.08.005"},{"key":"e_1_3_4_32_2","unstructured":"Thorne. Thorne Unveils New Gut Health Test Kit With Microbiome Wipe. https:\/\/www.thorne.com\/press-releases\/thorne-relaunches-its-gut-health-test-with-the-first-to-market-user-friendly-microbiome-wipe-that-revolutionizes-the-testing-experience (accessed 22 September 2023)."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00681-2"},{"key":"e_1_3_4_34_2","unstructured":"New York Times Magazine. The Woman Who Could Smell Parkinson\u2019s. https:\/\/www.nytimes.com\/2024\/06\/14\/magazine\/parkinsons-smell-disease-detection.html?ogrp=dpl&unlocked_article_code=1.SE4.TkH7.xK3wT09KkqkY&smid=url-share (2024)."},{"key":"e_1_3_4_35_2","first-page":"638","article-title":"Breath biopsy\u00ae to identify exhaled volatile organic compounds biomarkers for liver cirrhosis detection","volume":"11","author":"Ferrandino G","year":"2023","unstructured":"Ferrandino G, De Palo G, Murgia A, et al. Breath biopsy\u00ae to identify exhaled volatile organic compounds biomarkers for liver cirrhosis detection. J Clin Transl Hepatol 2023; 11: 638\u2013648.","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.06.001"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00328"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02632-7"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03962-x"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.867528"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26134"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0083-7"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00576-6"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16041"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0792"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02160-8"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jobcr.2015.08.006"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6569"},{"key":"e_1_3_4_49_2","unstructured":"Drugs.com. DaTscan Prices Coupons Copay Cards & Patient Assistance. https:\/\/www.drugs.com\/price-guide\/datscan"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.2196\/33944"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00721-2"},{"key":"e_1_3_4_52_2","article-title":"Improving outcomes through early diagnosis of Parkinson's disease","volume":"18","author":"Pagan FL","year":"2012","unstructured":"Pagan FL. Improving outcomes through early diagnosis of Parkinson's disease. Am J Manag Care 2012; 18: S176\u2013S182.","journal-title":"Am J Manag Care"},{"key":"e_1_3_4_53_2","article-title":"The effect of physical activity in Parkinson's disease: a mini-review","volume":"10","author":"Fayyaz M","year":"2018","unstructured":"Fayyaz M, Jaffery SS, Anwer F, et al. The effect of physical activity in Parkinson's disease: a mini-review. Cureus 2018; 10: e2995.","journal-title":"Cureus"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/2396987317753453"},{"key":"e_1_3_4_55_2","article-title":"Ethical considerations for identifying individuals in the prodromal\/early phase of Parkinson's disease: a narrative review","volume":"14","author":"Schaeffer E","year":"2024","unstructured":"Schaeffer E, Yilmaz R, St Louis EK, et al. Ethical considerations for identifying individuals in the prodromal\/early phase of Parkinson's disease: a narrative review. J Parkinsons Dis 2024; 14: S307\u2013S319.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209522"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251336118","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X251336118","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251336118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:51:33Z","timestamp":1777589493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X251336118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/1877718X251336118"],"URL":"https:\/\/doi.org\/10.1177\/1877718x251336118","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}